Clozapine-associated pneumonia and respiratory arrest secondary to severe constipation

Medicine, Science and the Law

Volumn 54, Issue 2, 2014, Pages 105-109

  Galappathie, Nuwan ^a   Khan, Sobia ^b  

^a ST ANDREW S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

clozapine; constipation; pneumonia; respiratory arrest; schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CONSTIPATION; FECES IMPACTION; HUMAN; MALE; PARANOID SCHIZOPHRENIA; PNEUMONIA; RESPIRATORY ARREST; RESPIRATORY FAILURE; SCHIZOPHRENIA; SIGMOIDOSCOPY;

CLOZAPINE; CONSTIPATION; PNEUMONIA; RESPIRATORY ARREST; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CONSTIPATION; FECAL IMPACTION; HUMANS; MALE; PNEUMONIA; RESPIRATORY INSUFFICIENCY; SCHIZOPHRENIA, PARANOID; SIGMOIDOSCOPY;

EID: 84896868891     PISSN: 00258024     EISSN: None     Source Type: Journal    
DOI: 10.1177/0025802413497708     Document Type: Article

References (37)

1. Alvir JM,Lieberman JA.Agranulocytosis: incidence and risk factors.J Clin Psychiatry. 1994;55:137-138.
2. Honigfield G.The Clozapine National Registry System: forty years of risk management.J Clin Psychiatry Monogr. 1996;14:29-32.
3. Young C,Bowers M,Mazure C.Management of the adverse effects of clozapine.Schizophr Bull. 1998;24:381-390.
4. Taylor DM,Douglas-Hall P,Olofinjana Bet al.Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long acting injection.B J Psychiatry. 2009;194:165-167.
5. Lieberman JA,Safferman AZ,Pollack Set al.Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.Am J Psychiatry. 1994;151:1744-1752.
6. Freudenreich O,Goff DC.Colon perforation and peritonitis associated with clozapine.J Clin Psychiatry. 2000;61:950-951.
7. Hayes G,Gibler B.Clozapine-induced constipation (letter).Am J Psychiatry. 1995;152:298-298.
8. Shammi CM,Remimgton G.Clozapine induced necrotizing colitis.J Clin Psychopharmacol. 1997;17:230-232.
9. Levin TT,Barrett J,Mendelowitz MD.Death from clozapine-induced constipation: case report and literature review.Psychosomatics. 2002;43:1-1.
10. Townsend G,Curtis D.Case report: rapidly fatal bowel ischaemia on clozapine treatment.BMC Psychiatry. 2006;6:43-43.
11. Lavi E,Rivkin L,Carmon Met al.Clozapine-induced colonic obstruction requiring surgical treatment.IMAJ. 2009;11:385-386.
12. Drew L,Herdson P.Clozapine and constipation: a serious issue.Aust N Z J Psychiatry. 1997;31:149-150.
13. Hibbard KR,Propst A,Frank DEet al.Fatalities associated with clozapine-related constipation and bowel obstruction: a literature review and two case reports.Psychosomatics. 2009;50:416-419.
14. Flanagan RJ,Ball RY.Gastrointestinal hypomotility: an under-recognised life-threatening adverse effect of clozapine.Forensic Sci Int. 2011;20:31-36.
15. Palmer SE,McLean RM,Ellis PMet al.Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.J Clin Psychiatry. 2008;69:759-768.
16. Cohen D,Bogers JP,van Dijik Det al.Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.J Clin Psychiatry. 2012;73:1307-1312.
17. Knol W,Marum RJ,Jansen PAet al.Antipsychotic drug use and risk of pneumonia in elderly people.J Am Geriatr Soc. 2008;56:661-666.
18. Trifirò G,Gambassi G,Sen EFet al.Association of community-acquired pneumonia with antipsychotic drug use in elderly patients. A nested case-control study.Ann Intern Med. 2010;152:418-425.
19. Patel S,Allin M.Physical complications in early clozapine treatment: a case report and implications for safe monitoring.Ther Adv Psychopharmacol. 2011;l:25-29.
20. Trifirò G.Antipsychotic drug use and community-acquired pneumonia.Curr Infect Dis Rep. 2011;13:262-268.
21. Kuo CJ,Yang SY,Liao YTet al.Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.Schizophrenia Bull. 2013;39:648-657.
22. Van Tol HHM,Bunzow JR,Guan HCet al.Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.Nature. 1991;350:610-614.
23. Baldessarini RJ,Frankenburg DR.Clozapine: a novel antipsychotic agent.New Engl J Med. 1991;324:746-754.
24. Jann M,Grimsley S,Gray Eet al.Pharmacodynamics and pharmacokinetics of clozapine.Clin Pharmacokinet. 1993;24:161-176.
25. Chengappa K,Pollock B,Parepally Het al.Anticholinergic differences among patients receiving standard clinical doses of olanzapine and clozapine.J Clin Psychopharmacol. 2000;20:311-316.
26. Hinkes R,Quesada TV,Currier MBet al.Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea.J Clin Pharmacol. 1996;16:462-463.
27. Stewart JT.Reversible dysphagia associated with neuroleptic treatment.J Am Geriatr Soc. 2001;49:1260-1261.
28. Maddalena AS,Fox M,Hofmann Met al.Esophageal dysfunction on psychotropic medication. A case report and literature review.Pharmacopsychiatry. 2004;37:134-138.
29. Gerson SL,Aree C,Meltzer HY.N-desmethyl-clozapine: a clozapine metabolite that suppresses haemopoiesis.Br J Haematol. 1994;86:555-561.
30. Raaska K,Raitasuo V,Arstila Met al.Bacterial pneumonia can increase serum concentration of clozapine.Eur J Clin Pharmacol. 2002;58:321-322.
31. Haack MJ,Bak ML,Beurskens Ret al.Toxic rise of clozapine plasma concentrations in relation to inflammation.Eur Neuropsychopharmacol. 2003;13:381-385.
32. De Leon J,Diaz FJ.Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report.Progr Neuropsychopharmacol Biol Psychiatry. 2003;27:1059-1063.
33. Mathew T,Desmond P,Isaacs D.Constipation: it can be severe with clozapine.Aust Adv Drug React Bull. 1999;18:2-2.
34. Dworkin RH.Pain insensitivity in schizophrenia: a neglected phenomenon and some implications.Schizophr Bull. 1994;20:235-248.
35. Liana C,Hsieh MD.Psychopharmacology for the clinician. Myoclonus as an indicator of infection in patients with schizophrenia treated with clozapine.J Psychiatry Neurosci. 2011;36:1-1.
36. Lennard-Jones JE.Clinical management of constipation.Pharmacology. 1993;47:216-223.
37. Haack MJ,Bak ML,Beurskens Ret al.Toxic rise of clozapine plasma concentrations in relation to inflammation.Eur Neuropsychopharmacol. 2003;13:381-385.